126 related articles for article (PubMed ID: 27418712)
1. Discovery of Novel Biomarkers for Alzheimer's Disease from Blood.
Long J; Pan G; Ifeachor E; Belshaw R; Li X
Dis Markers; 2016; 2016():4250480. PubMed ID: 27418712
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
3. Identification of a blood-based biomarker panel for classification of Alzheimer's disease.
Laske C; Leyhe T; Stransky E; Hoffmann N; Fallgatter AJ; Dietzsch J
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1147-55. PubMed ID: 21466745
[TBL] [Abstract][Full Text] [Related]
4. A candidate plasma protein classifier to identify Alzheimer's disease.
Zhao X; Lejnine S; Spond J; Zhang C; Ramaraj TC; Holder DJ; Dai H; Weiner R; Laterza OF
J Alzheimers Dis; 2015; 43(2):549-63. PubMed ID: 25114072
[TBL] [Abstract][Full Text] [Related]
5. [Down-regulation of Ech1 decreases the adhesion ability of mouse hepatocarcinoma Hca-F cells].
Zhang J; Tang JW; Sun MZ; Liu SQ; Song MY; Wang B; Song B; Huang YH
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):605-10. PubMed ID: 23207155
[TBL] [Abstract][Full Text] [Related]
6. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
[TBL] [Abstract][Full Text] [Related]
7. Plasma Proteomics Biomarkers in Alzheimer's Disease: Latest Advances and Challenges.
Perneczky R; Guo LH
Methods Mol Biol; 2016; 1303():521-9. PubMed ID: 26235089
[TBL] [Abstract][Full Text] [Related]
8. Beyond statistics: a new combinatorial approach to identifying biomarker panels for the early detection and diagnosis of Alzheimer's disease.
Milward EA; Moscato P; Riveros C; Johnstone DM
J Alzheimers Dis; 2014; 39(1):211-7. PubMed ID: 24145380
[TBL] [Abstract][Full Text] [Related]
9. Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease.
Shah DJ; Rohlfing F; Anand S; Johnson WE; Alvarez MT; Cobell J; King J; Young SA; Kauwe JS; Graves SW
J Alzheimers Dis; 2016; 49(2):317-27. PubMed ID: 26484917
[TBL] [Abstract][Full Text] [Related]
10. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
[TBL] [Abstract][Full Text] [Related]
11. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.
Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Yu Z
Mol Med Rep; 2016 Oct; 14(4):3184-98. PubMed ID: 27511317
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Ech1 overexpression on biological behavior of mouse hepatocarcinoma Hca-P cells in vitro].
Wang M; Song B; Wang B; Zhang J; Tang JW
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):337-40. PubMed ID: 24054008
[TBL] [Abstract][Full Text] [Related]
13. Organ-specific aging in the plasma proteome predicts disease.
Duggan MR; Walker KA
Trends Mol Med; 2024 May; 30(5):423-424. PubMed ID: 38302317
[TBL] [Abstract][Full Text] [Related]
14. Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease.
Stevenson A; Lopez D; Khoo P; Kalaria RN; Mukaetova-Ladinska EB
J Alzheimers Dis; 2017; 60(3):845-857. PubMed ID: 28984593
[TBL] [Abstract][Full Text] [Related]
15. A novel method and software for automatically classifying Alzheimer's disease patients by magnetic resonance imaging analysis.
Previtali F; Bertolazzi P; Felici G; Weitschek E
Comput Methods Programs Biomed; 2017 May; 143():89-95. PubMed ID: 28391822
[TBL] [Abstract][Full Text] [Related]
16. Role of Plasma Clusterin in Alzheimer's Disease-A Pilot Study in a Tertiary Hospital in Northern India.
Vishnu VY; Modi M; Sharma S; Mohanty M; Goyal MK; Lal V; Khandelwal N; Mittal BR; Prabhakar S
PLoS One; 2016; 11(11):e0166369. PubMed ID: 27861589
[TBL] [Abstract][Full Text] [Related]
17. Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients.
Laske C; Schmohl M; Leyhe T; Stransky E; Maetzler W; Berg D; Fallgatter AJ; Joos T; Dietzsch J
J Alzheimers Dis; 2013; 34(2):367-75. PubMed ID: 23207486
[TBL] [Abstract][Full Text] [Related]
18. Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer's disease.
Sutcliffe JG; Hedlund PB; Thomas EA; Bloom FE; Hilbush BS
J Neurosci Res; 2011 Jun; 89(6):808-14. PubMed ID: 21374699
[TBL] [Abstract][Full Text] [Related]
19. Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease.
Yang MH; Yang YH; Lu CY; Jong SB; Chen LJ; Lin YF; Wu SJ; Chu PY; Chung TW; Tyan YC
J Proteomics; 2012 Jun; 75(12):3617-29. PubMed ID: 22554909
[TBL] [Abstract][Full Text] [Related]
20. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
Hong H; Li Y; Su B
J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
